Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer
The Long Run with Luke Timmerman
Exploring the Versatility and Innovation of Bi-Specific Antibodies in Biotech
Exploring the recent advancements and potential of bi-specific antibodies compared to monoclonal antibodies, with a focus on their diverse mechanisms and applications in cancer treatment.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
